Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Company News

Sage launches Alzheimer's analytics platform

July 27, 2018 3:31 PM UTC

Sage Bionetworks (Seattle, Wash.) said it launched the Agora platform, "an interactive, web-based tool that allows researchers to explore curated genomic analyses" of Alzheimer’s disease. The platform includes a list of early candidate target nominations for AD.

The platform pools together five years of research from scientists with the Accelerating Medicines Partnership - Alzheimer’s Disease (AMP-AD) Target Discovery and Preclinical Validation Project, which is led by the NIH...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article

BCIQ Company Profiles

Sage Bionetworks